2DFX

crystal structure of the carboxy terminal domain of colicin e5 complexed with its inhibitor

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: E-I
  • Int. Res.: 114
  • Norm. En. per Res.: -5.0244
• Hub Node: E(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
E-I	-145.3158	-70.1274	-357.343	-572.7862	114	20	2	14532	7	55	33

Interface residues

• E-I: ALA24I, ALA66I, ALA72E, ALA87I, ARG107E, ARG27E, ARG33E, ARG56E, ARG61I, ARG68E, ARG85I, ASN23I, ASN83I, ASN90I, ASN97I, ASP104E, ASP105E, ASP23E, ASP51I, ASP54E, ASP63I, ASP64E, ASP71I, ASP93I, ASP94I, ASP96E, ASP99E, GLN24E, GLN29E, GLN93E, GLU32E, GLU6I, GLU74I, GLU82I, GLU89I, GLU90E, GLU96I, GLY101E, GLY22I, GLY28E, GLY34E, GLY49I, GLY52I, GLY59I, HIS54I, HIS7I, ILE103I, ILE104I, ILE108E, ILE22E, ILE26E, ILE47I, ILE50I, ILE62I, ILE91I, ILE94E, ILE95I, LEU106I, LEU48I, LEU56I, LEU86I, LYS107I, LYS21E, LYS21I, LYS25E, LYS27I, LYS3I, LYS55E, LYS59E, LYS60E, LYS79I, LYS92I, LYS97E, MET108I, MET26I, MET30E, MET72I, PHE102I, PHE17I, PHE53E, PHE5I, PHE60I, PRO100E, PRO31E, PRO58E, PRO58I, PRO62E, PRO63E, PRO73I, SER106E, SER25I, SER52E, SER57E, SER64I, SER65I, SER67I, SER95E, THR105I, THR61E, THR69I, THR8I, THR92E, THR98E, TRP102E, TRP46I, TRP55I, TRP68I, TYR65E, TYR70I, TYR81E, TYR99I, VAL103E, VAL83E, VAL91E